HB1375 - EFFECTIVE Act Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act
US Congress - 118th Congress
Introduced byDavid John Trone, Dan Meuser, Ann M. Kuster
Last updated over 1 year ago
6 Co-Sponsors
To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now